Industry is increasingly exploring the use of AI chatbots to potentially diagnose and treat various medical conditions, including in the area of mental health. FDA is just beginning to develop its regulatory framework for approved, cleared, or authorized devices in the mental health space based on generative AI technology. The medtech industry, healthcare providers, and
Latest Post
More Posts
FDA Release of Complete Response Letters Raises Confidentiality, Disclosure Questions But Offers Insights for Development
U.S. HHS Office of General Counsel Statement of Organization Suggests Potential Consolidation, Expansion of Authority
The AI Revolution and the FDA: Becky Wood and Deeona Gaskin’s Fireside Chat with Former FDA Commissioner Dr. Scott Gottlieb
FDA Offers New Clinical Trial Guidance for Oncology Accelerated Approval
Subscribe: Subscribe via RSS
Blogs
Firm/Org